The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.
 
Shirish M. Gadgeel
Consulting or Advisory Role - Boehringer Ingelheim
 
Manuel Cobo Dols
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Jean-Charles Soria
Honoraria - BBI Healthcare; Roche Pharma AG
 
Ki Hyeong Lee
No Relationships to Disclose
 
Shun Lu
Consulting or Advisory Role - Boehringer Ingelheim; Roche Pharma AG
 
Vassilis Georgoulias
Honoraria - Amgen; Astellas Pharma; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Novartis (Inst); Sanofi (Inst)
 
Andrea Fulop
No Relationships to Disclose
 
Erdem Goker
No Relationships to Disclose
 
Konstantinos N. Syrigos
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Roche
 
Alessandro Morabito
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Pfizer
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Roche Pharma AG
 
Hasan Senol Coskun
Speakers' Bureau - Sanofi
 
Salih Zeki Guclu
Research Funding - Abbvie; Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Wei Li
No Relationships to Disclose
 
Sanjay Popat
Research Funding - Boehringer Ingelheim (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Andrea Ardizzoni
No Relationships to Disclose
 
Juliane Lungershausen
Employment - Boehringer Ingelheim
 
Bushi Wang
Employment - Boehringer Ingelheim
 
Vikram K. Chand
Employment - Boehringer Ingelheim
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I)
Research Funding - Boehringer Ingelheim
 
Glenwood D. Goss
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim